NKCC1 and hypertension: Role in the regulation of vascular smooth muscle contractions and myogenic tone

Annals of Medicine

Volumn 44, Issue SUPPL. 1, 2012, Pages

  Orlov, Sergei N ^a,b,c   Koltsova, Svetlana V ^a   Tremblay, Johanne ^a   Baskakov, Mikhail B ^d   Hamet, Pavel ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^d SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Hypertension; K+ 2Cl cotransport; myogenic tone; Na+; vascular smooth muscle contractions

Indexed keywords

AMLODIPINE; ANGIOTENSIN II; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FUROSEMIDE; LOOP DIURETIC AGENT; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; PHENYLEPHRINE; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 1; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 2; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

AFRICAN AMERICAN; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; DEPOLARIZATION; DRUG TARGETING; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY BLOOD VESSEL; KIDNEY DISEASE; KIDNEY FAILURE; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTENSION; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; VASOCONSTRICTION;

EID: 84862512476     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2011.653395     Document Type: Review

References (73)

1. Bianchi G, Ferrari P, Trizio P, Ferrandi M, Torielli L, Barber BR, et al. Red blood cell abnormalities and spontaneous hypertension in rats. A genetically determined link. Hypertension. 1985;7:319-25. (Pubitemid 15021169)
2. 2hybrids of spontaneously hypertensive and normotensive rats]. Bull Exp Biol Med. 1987;103:456-8.
3. Orlov SN, Adragna N, Adarichev VA, Hamet P. Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension. Am J Physiol. 1999;276: C511-36. (Pubitemid 29157367)
4. Garay RP, Alda O. What can we learn from erythrocyte Na-K-Cl cotransporter NKCC1 in human hypertension. Pathophysiology. 2007;14:167-70. (Pubitemid 350176654)
5. Jiang G, Akar F, Cobbs SL, Lomashvilli K, Lakkis R, Gordon FJ, et al. Blood pressure regulates the activity and function of Na-K-2Cl cotransporter in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2004;286:H1552-7. (Pubitemid 38381167)
6. Orlov SN, Gossard F, Pausova Z, Akimova OA, Tremblay J, Grim CE, et al. Decreased NKCC1 activity in erythrocytes from African-Americans with hypertension and dyslipidemia. Am J Hypertens. 2010;23:321-6.
7. Gamba G. Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. Physiol Rev. 2005;85:423-93. (Pubitemid 40404634)
8. Orlov SN, Mongin AA. Salt sensing mechanisms in blood pressure regulation and hypertension. Am J Physiol Heart Circ Physiol. 2007;293:H2039-53. (Pubitemid 47605848)
9. Orlov SN, Tremblay J, Hamet P. NKCC1 and hypertension: a novel therapeutic target involved in regulation of vascular tone and renal function. Curr Opin Nephrol Hypertens. 2010;19:163-8.
10. Chipperfield AR, Harper AA. Chloride in smooth muscle. Prog Biophys Mol Biol. 2001;74:175-221. (Pubitemid 32168154)
11. Davis JPL, Chipperfield AR, Harper AA. Accumulation of intracellular chloride by (Na-K-Cl) cotransport in rat arterial smooth muscle is enhanced in deoxycorticosterone acetate (DOCA)/salt hypertension. J Mol Cell Cardiol. 1993;25: 233-7. (Pubitemid 23154944)
12. 2+ channels. Pflügers Archiv. 2004;449:42-55.
13. Barthelmebs M, Stephan D, Fontaine C, Grima M, Imbs JL. Vascular effects of loop diuretics: an in vivo and in vitro study in the rat. Naunyn-Schmiedebergs Arch Pharmacol. 1994;349: 209-16. (Pubitemid 24059768)
14. Lavallee SL, Iwamoto LM, Claybaugh JR, Dressel MV, Sato AK, Nakamura KT. Furosemide-induced airway relaxation in guinea pigs: relation to Na-K-2Cl cotransporter function. Am J Physiol. 1997;273:L211-6.
15. Tian R, Aalkjaer C, Andreasen F. Mechanisms behind the relaxing effect of furosemide on the isolated rabbit ear artery. Pharmacol Toxicol. 1990;67:406-10.
16. -cotransport inhibitor bumetanide on electrical and contractile activity of smooth muscle cells in guinea pig ureter. Bull Exp Biol Med. 2003;136:145-9.
17. - cotransport and chloride permeability of the cell membrane in mezaton and histamine regulation of electrical and contractile activity in smooth muscle cells from the guinea pig ureter. Russian Physiol J. 2008;93:306-17.
18. Stanke F, Devillier P, Breant D, Chavanon O, Sessa C, Bricca G, et al. Furosemide inhibits angiotensin II-induced contraction on human vascular smooth muscle. Br J Clin Pharmacol. 1998;46:571-5.
19. Stanke-Labesque F, Craciwski JL, Bedouch P, Chavanon O, Magne JL, Bessard G, et al. Furosemide inhibits thrombaxane A2-induced contraction in isolated human internal artery and saphenous vein. J Cardiovasc Pharmacol. 2000;35: 531-7. (Pubitemid 30185451)
20. Wang X, Breaks J, Loutzenhiser K, Loutzenhiser R. Effects of inhibition of the Na+/K+/2Cl- cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole. Am J Physiol Renal Physiol. 2007;292:F999-1006.
21. 2+ influx pathways associated with oxytocin-induced contractions of rat myometrium. Gen Physiol Biophys. 1995;14:427-36.
22. Mozhayeva MG, Bagrov YY, Ostretsova IB, Gillespie JI. The effect of furosemide on oxytocin-induced contractions of the rat myometrium. Exp Physiol. 1994;79:661-7. (Pubitemid 24293707)
23. -cotransporter in rat aorta. Am J Physiol. 1999;276:C1383-90.
24. Garg P, Martin C, Elms SC, Gordon FJ, Wall SM, Garland CJ, et al. Effect of the Na-K-2Cl cotransporter NKCC1 on systematic blood pressure and smooth muscle tone. Am J Physiol Heart Circ Physiol. 2007;292:H2100-5. (Pubitemid 47084588)
25. - cotransporter is implicated in gender differences in the response of the rat aorta to phenylephrine. Br J Pharmacol. 2006;148:964-72.
26. - cotransport-dependent signaling. Purinergic Signal. 2009;5:343-9.
27. Koltsova SV, Kotelevtsev SV, Tremblay J, Hamet P, Orlov SN. Excitation-contraction coupling in resistant mesenteric arteries: evidence for NKCC1-mediated pathway. Biochem Biophys Res Commun. 2009;379:1080-3.
28. -cotransporter. Am J Physiol. 2002;283:H1846-55.
29. -cotransporter 1 in spontaneously hypertensive rats. Biochem Biophys Res Commun. 2010;396:252-7.
30. Yang S-S, Lo Y-F, Wu C-C, Lin S-W, Yeh C-J, Chu P, et al. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol. 2010;21:1868-77.
31. Vitari AC, Thastrup J, Rafigi FH, Deak M, Morrice NA, Karlsson HK, et al. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1. Biochem J. 2006;397:223-31. (Pubitemid 44032854)
32. Flagella M, Clarke LL, Miller ML, Erway LC, Giannella RA, Andriga A, et al. Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem. 1999;274:26946-55.
33. Wall SM, Knepper MA, Hassel KA, Fischer MP, Shodeinde A, Shin W, et al. Hypotension in NKCC1 null mice: role of the kidney. Am J Physiol Renal Physiol. 2006;290:F409-16. (Pubitemid 43724994)
34. Kim SM, Eisner C, Faulhaber-Walter R, Mizel D, Wall SM, Briggs JP, et al. Salt sensitivity of blood pressure in NKCC1-deficient mice. Am J Physiol Renal Physiol. 2008;295: F1230-8.
35. + co-transport in cultured vascular smooth muscle cells from spontaneously hypertensive rats: baseline activity and regulation. J Hypertens. 1992;10:733-40.
36. Jiang G, Cobbs S, Klein JD, O'Neill WC. Aldosterone regulates the Na-K-Cl cotransporter in vascular smooth muscle. Hypertension. 2003;41:1131-5. (Pubitemid 36548615)
37. Orlov SN, Li J-M, Tremblay J, Hamet P. Genes of intracellular calcium metabolism and blood pressure control in primary hypertension. Semin Nephrol. 1995;15:569-92.
38. Hamet P, Orlov SN, Tremblay J. Intracellular signalling mechanisms in hypertension. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and treatment. New York: Raven Press; 1995. p. 575-608.
39. Gagnon F, Delpire E. Multiple pathways for protein phosphatase 1 (PP1) regulation of Na-K-2Cl cotransporter (NKCC1) function: the N-terminal tail of the Na-K-2Cl cotransporter serves as a regulator scaffold for the Ste20-related proline/alanine-rich kinase (SPAK) and PP1. J Biol Chem. 2010;285:14115-21.
40. Sid B, Miranda L, Vertommen D, Viollet B, Rider MH. Stimulation of human and mouse erythrocyte Na+-K+-2Cl-cotransport by osmotic shrinkage does not involve AMP-activated protein kinase, but is associated with STE20/SPS1-related proline/alanine-rick kinase activation. J Physiol. 2010;588:2315-28.
41. Hannemann A, Flatman PW. Phosphorylation and transport in the Na-K-2Cl cotransporters, NKCC1 and NKCC2A, compared in HEK-293 cells. PLoS One. 2011;25:e17992.
42. Bergaya S, Faure S, Baudrie V, Rio M, Escoubet B, Bonnin P, et al. WNK1 regulates vasoconstriction and blood pressure response to a 1-adrenergic stimulation in mice. Hypertension. 2011;58:439-45.
43. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001;293: 1107-12. (Pubitemid 32758085)
44. San-Cristobal P, de los Heros P, Ponce-Coria J, Moreno T, Gamba G. WNK kinases, renal ion transport and hypertension. Am J Nephrol. 2008;28:860-70.
45. Rafigi FH, Zuber AM, Glover M, Richardson C, Fleming S, Jovanovic A, et al. Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol Med. 2010;2:63-75.
46. - cotransporter is epigenetically regulated during postnatal development of hypertension. Am J Hypertens. 2011;24:1286-93.
47. Schubert R, Mulvany MJ. The myogenic response: established facts and attractive hypothesis. Clin Sci. 1999;96:313-26. (Pubitemid 29179136)
48. Hill MA, Davis MJ, Meininger GA, Potocnik SJ, Murphy TV. Arteriolar myogenic signaling mechanisms: implications for local vascular functions. Clin Hemorheol Microcirc. 2006;34:67-79. (Pubitemid 43351012)
49. Schubert R, Lidington D, Bolz S-S. The emerging role of Ca 2 1 sensitivity regulation in promoting myogenic vasoconstriction. Cardiovasc Res. 2008;77:8-18. (Pubitemid 351195169)
50. Loutzenhiser R, Bidani AK, Wang X. Systolic pressure and the myogenis response of the afferent arteriole. Acta Physiol Scand. 2004;181:407-13. (Pubitemid 39078836)
51. Lagaud G, Gaudreault N, Moore EDW, Van Breemen C, Laher I. Pressure-dependent myogenic constriction of cefrebral arteries occurs independently of voltage-dependent activation. Am J Physiol Heart Circ Physiol. 2002;283: H2187-95. (Pubitemid 35345918)
52. Adragna N, White RE, Orlov SN, Lauf PK. K-Cl cotransport in vascular smooth muscle and erythrocytes: possible implication in vasodilation. Am J Physiol. 2000;278:C381-90. (Pubitemid 30131156)
53. Folkow B. Cardiovascular "remodeling" in rat and human: time axis, extent, and in vivo relevance. Physiology (Bethesda). 2010;25:264-5.
54. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1153-67.
55. Liu Y, Gutterman DD. Vascular control in humans: focus on the coronary micocirculation. Basic Res Cardiol. 2009;104: 211-27.
56. Bidani A, Griffin KA, Williamson G, Wang X, Loutzenhiser R. Protective importance of the myogenic response in the renal circulation. Hypertension. 2009;54:393-8.
57. Nathan S, Pepine CJ, Bakris GL. Calcium antagonists: effects on cardio-renal risk in hypertensive patients. Hypertension. 2005;46:637-42. (Pubitemid 43186729)
58. Griffin KA, Picken MM, Bakris GL, Bidani AK. Class differences in the effects of calcium channel blockers in the rat remnant kidney model. Kidney Int. 1999;55:1849-60. (Pubitemid 29197972)
59. Bakris GL, Toto RD, McCullough PA, Rocha R, Purkayastha D, Davis P, et al. Effect of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int. 2008;73:1303-9. (Pubitemid 351693145)
60. Shibata MC, Leon H, Chatterley T, Dorgan M, Vandermeer B. Do calcium channel blockers increase the diagnosis of heart failure with hypertension? Am J Cardiol. 2010;106: 228-35.
61. Loutzenhiser R, Epstein M. The renal hemodynamic effects of calcium antagonists. In: Epstein M, Loutzenhiser R, editors. Calcium antagonists and the kidney. Philadelphia: Hanley & Belfus, Inc.; 1990. p. 33-74.
62. Hayashi K, Homma K, Wakino S, Tokuyama H, Sugano N, Saruta T, et al. T-type channel blockage as a determinant of kidney protection. Keio J Med. 2010;59:84-95.
63. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Physiological role for P2X 1 receptors in renal microvascular autoregulatory behavior. J Clin Invest. 2003;112:1895-905. (Pubitemid 38063713)
64. Hansen PB, Jensen BL, Andreasen D, Scott O. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res. 2001;89: 630-8. (Pubitemid 32924218)
65. - cotransport and salt retention in Blacks: a provocative hypothesis. J Hypertens. 2005;23:1929-30.
66. Boone CA. End-stage renal disease in African-Americans. Nephrol Nurs J. 2000;27:597-600.
67. Kotchen TA, Piering AW, Cowley AW, Grim CE, Gaudet D, Hamet P, et al. Glomerular hyperfiltration in hypertensive African Americans. Hypertension. 2000;35:822-6. (Pubitemid 30165332)
68. Orlov SN, Resink TJ, Bernhardt J, Buhler FR. Volume-dependent regulation of sodium and potassium fluxes in cultured vascular smooth muscle cells: dependence on medium osmolality and regulation by signalling systems. J Membrane Biol. 1992;126:199-210.
69. Koltsova SV, Gusakova SV, Anfinogenova YJ, Baskakov MB, Orlov SN. Vascular smooth muscle contraction evoked by cell volume modulation: role of cytoskeleton network. Cell Physiol Biochem. 2008;21:29-36.
70. Orlov SN, Hamet P. Intracellular monovalent ions as second messengers. J Membr Biol. 2006;210:161-72. (Pubitemid 44306221)
71. Hannaert P, Alvarez-Guerra M, Pirot D, Nazaret C, Garay RP. Rat NKCC2/NKCC1 cotransport selectivity for loop diuretic drugs. Naunyn-Schmiedebergs Arch Pharmacol. 2002;365:193-9. (Pubitemid 34212230)
72. Delpire E, Lu J, England R, Dull C, Thorne T. Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter. Nat Genet. 1999;22: 192-5. (Pubitemid 29264817)
73. Lang F, Vallon V, Knipper M, Wangemann P. Functional significance of channels and transporters expressed in the inner ear and kidney. Am J Physiol Cell Physiol. 2007;293: C1187-208. (Pubitemid 47558943)